Bio Essence Corp. is a herbal health, diet, and nutrition company. The Company is mainly engaged in selling health supplements and providing original equipment manufacturing (OEM) services. The Company also outsources manufacturing / OEM services.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
30/26/30	$0.4700	+6.82%	1,000

Delayed Quote OTC Markets

More quotes

Market Closed - OTC Markets 07:00:00 30/10/2026 pm IST			5-day change	1st Jan Change
0.4700 ^USD	+6.82%		+11.88%	+683.33%

24/10	Bio Essence Corp. Announces Board Changes, Effective October 19, 2026	CI
15/08	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Market Cap	2.53Cr 2.26Cr 2.07Cr 1.88Cr 3.53Cr 239.42Cr 3.6Cr 25Cr 9.98Cr 126.37Cr 9.49Cr 9.29Cr 399.15Cr	P/E 2024	-7x	P/E 2025	2.54x
Enterprise Value	2.69Cr 2.4Cr 2.2Cr 2Cr 3.75Cr 254.22Cr 3.83Cr 26Cr 11Cr 134.18Cr 10Cr 9.86Cr 423.82Cr	EV / Sales 2024	36.6x	EV / Sales 2025	2.03x
Free-Float	36.08%	Yield 2024 *	-	Yield 2025	-

24/10	Bio Essence Corp. Announces Board Changes, Effective October 19, 2026	CI
15/08	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
19/05	Bio Essence Corporation completed the acquisition of MediFlow AI from Zhituo Software Co., Limited.	CI
15/05	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
25/04	Bio Essence Corporation has entered into a Asset Purchase Agreement to acquire MediFlow AI from Zhituo Software Co., Limited for $3.1 million.	CI
28/03	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
27/03	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
12/11	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/25/14	Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/25/15	Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
28/25/28	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/25/28	Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	CI
15/24/15	Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

12/11	Bio Essence : Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q)	PU
08/24/08	Bio Essence : Amendment to Quarterly Report Form 10 Q/A	PU
07/24/07	Bio Essence : Non Reliance of Financial Report Form 8 K	PU
31/23/31	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)	AQ
16/22/16	BIO ESSENCE CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ

Bio Essence Corporation Share Price

Stocks

BIOE

US09090C1053

Pharmaceuticals

Valuation: Bio Essence Corporation

Chart: Bio Essence Corporation

Latest news: Bio Essence Corporation

Press Releases: Bio Essence Corporation

Quotes and Performance

Price Extremes

Managers and Directors: Bio Essence Corporation

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 day	+6.82%
1 week	+11.88%
1 month	+158.38%
3 months	+73.88%
6 months	-6.00%
Current year	+683.33%

1 week	0.4	0.47
1 month	0.19	0.47
Current year	0.05	0.52
1 year	0.05	0.52
3 years	0.05	10.81
5 years	0.05	10.81
10 years	0.05	10.81

Manager	Title	Age	Since
Yin Yan CEO	Chief Executive Officer	50	-
Bill Sluss DFI	Director of Finance/CFO	71	07/09/2023
Tuan Tran COO	Chief Operating Officer	52	01/01/2018

Director	Title	Age	Since
Yin Yan CHM	Chairman	50	-
Siyavash Fooladian BRD	Director/Board Member	54	-
Bill Sluss BRD	Director/Board Member	71	18/06/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
28/10/24	Yin Yan	Sell	Chief Executive Officer	3,23,845	0.8520%
11/07/24	Yin Yan	Sell	Chief Executive Officer	92,190	0.2425%
02/07/24	Yin Yan	Sell	Chief Executive Officer	2,23,965	0.5892%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIO ESSENCE CORPORATION	+6.82%	+11.88%	+561.97%	-7.84%	2.53Cr
ELI LILLY AND COMPANY	-0.46%	+10.80%	+63.52%	+154.48%	1,26300Cr
JOHNSON & JOHNSON	-0.97%	+2.56%	+43.25%	+81.96%	66TCr
ABBVIE INC.	-2.05%	+1.12%	+32.47%	+102.74%	52TCr
ROCHE HOLDING AG	-1.54%	+1.61%	+53.42%	+67.10%	39TCr
MERCK & CO., INC.	-0.78%	+2.13%	+72.55%	+44.25%	37TCr
NOVARTIS AG	-1.69%	+2.75%	+32.49%	+54.35%	31TCr
ASTRAZENECA PLC	-0.72%	+8.08%	+11.15%	+34.09%	29TCr
AMGEN INC.	-0.12%	+5.96%	+55.97%	+78.44%	25TCr
GILEAD SCIENCES, INC.	-0.21%	+9.16%	+42.19%	+112.41%	21TCr
Average	+0.15%	+6.50%	+96.90%	+72.20%	42.62TCr
Weighted average by Cap.	-0.45%	+6.60%	+49.15%	+97.42%

	2024	2025
Net sales	3L 3L 3L 2L 5L 3.07Cr 5L 31.7L 12.78L 1.62Cr 12.16L 11.9L 5.11Cr	18.98L 16.94L 15.55L 14.14L 26.51L 18Cr 27.04L 1.86Cr 74.85L 9.48Cr 71.22L 69.7L 30Cr
Net income	-13.09L -11.68L -10.72L -10L -18.29L -12Cr -18.65L -1.28Cr -51.63L -6.54Cr -49.12L -48.07L -21Cr	9L 8L 7L 7L 12.52L 8.48Cr 12.77L 87.7L 35.35L 4.48Cr 33.64L 32.92L 14Cr
Net Debt	27.03L 24.14L 22.15L 20.15L 37.77L 26Cr 38.53L 2.65Cr 1.07Cr 14Cr 1.01Cr 99.3L 43Cr	15.63L 13.95L 12.81L 11.65L 21.84L 15Cr 22.27L 1.53Cr 61.65L 7.81Cr 58.66L 57.41L 25Cr